ArticleHealth science reports2026
Understanding Delays in Breast Cancer Diagnosis in Bangladesh: A Facility-Based Cross-Sectional Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: This study investigates factors contributing to delays in breast cancer diagnosis in Bangladesh and their impact on cancer staging. Early detection is crucial for effective treatment, yet many women in low- and middle-income countries (LMICs) are diagnosed at advanced stages, resulting in poorer outcomes. Methods: A cross-sectional study was conducted at two major cancer care facilities in Dhaka. Women aged 18 and older with suspected or confirmed breast cancer were included. Data were collected using a structured questionnaire on sociodemographic and clinical variables. Total delay, defined as the time from symptom recognition to treatment initiation, was categorized into patient delay (symptom recognition to first medical consultation) and provider delay (first consultation to treatment start). Multivariable logistic regression analyses identified factors associated with these delays. Results: Among 355 participants, 55.7% experienced total delays of over 4 months, with the highest delays in stage III cases (51.5%) due to patient delays. Key factors contributing to patient delay included low education (AOR: 1.43, 95% CI: 1.17-3.05), low monthly income (AOR: 3.41, 95% CI: 1.65-7.30), and absence of breast pain (AOR: 0.50, 95% CI: 0.26-0.96). Provider delays were significantly associated with rural residence (AOR: 3.07, 95% CI: 1.49-6.98) and the presence of nipple discharge (AOR: 2.92, 95% CI: 1.04-8.06). Total delays were most prevalent among patients from the Rangpur division (AOR: 5.87, 95% CI: 2.11-6.59), those residing in rural areas (AOR: 2.74, 95% CI: 1.40-5.52), and individuals with low education (AOR: 2.33, 95% CI: 1.09-5.11). Clinical factors such as breast pain (AOR: 2.34, 95% CI: 1.22-4.60) were also significantly associated with delay, along with discomfort discussing symptoms with a spouse (AOR: 2.16, 95% CI: 1.03-4.68). Additionally, nearly 80% of patients delayed seeking medical attention due to the belief that symptoms would resolve spontaneously, while 75% cited negligence and 65.5% reported financial barriers. Conclusions: Significant delays in breast cancer diagnosis in Bangladesh are driven by socio-economic factors and inadequate healthcare access. Increasing public awareness, especially in rural areas, and improving healthcare accessibility are essential to facilitate early detection. Expanding screening programs and training healthcare providers in early cancer detection are critical to improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.